The F-statistic for the selected instrument variant (rs2268650) was 49.25, suggesting that there was little possibility of weak instrument bias in our study
If both values remain within normal limits, ongoing routine monitoring is not necessary unless other hepatically cleared drugs are added
Deiana M, Rosa A, Casu V, Piga R, Assunta Dess M, Aruoma OI
Instead, CMS is extending the duration of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
Furthermore, this same study found that most individuals using either tirzepatide or semaglutide achieved a weight loss of at least 5% of their initial body weight after one year of treatment